Recent Updates on Acquired Hepatocerebral Degeneration.
Open Access
- 5 September 2017
- journal article
- review article
- Published by Ubiquity Press, Ltd.
- Vol. 7, 463
Abstract
Acquired hepatocerebral degeneration (AHD) refers to a chronic neurological syndrome in patients with advanced hepatobiliary diseases. This comprehensive review focuses on the pathomechanism and neuroimaging findings in AHD. A PubMed search was performed using the terms "acquired hepatocerebral degeneration," "chronic hepatocerebral degeneration," "Non-Wilsonian hepatocerebral degeneration," "cirrhosis-related parkinsonism," and "manganese and liver disease." Multiple mechanisms involving the accumulation of toxic substances such as ammonia or manganese and neuroinflammation may lead to widespread neurodegeneration in AHD. Clinical characteristics include movement disorders, mainly parkinsonism and ataxia-plus syndrome, as well as cognitive impairment with psychiatric features. Neuroimaging studies of AHD with parkinsonism show hyperintensity in the bilateral globus pallidus on T1-weighted magnetic resonance images, whereas molecular imaging of the presynaptic dopaminergic system shows variable findings. Ataxia-plus syndrome in AHD may demonstrate high-signal lesions in the middle cerebellar peduncles on T2-weighted images. Future studies are needed to elucidate the exact pathomechanism and neuroimaging findings of this heterogeneous syndrome.Keywords
This publication has 90 references indexed in Scilit:
- Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patientsNeurological Sciences, 2013
- The Effect of Hepatic Encephalopathy, Hepatic Failure, and Portosystemic Shunt on Brain Volume of Cirrhotic Patients: A Voxel-Based Morphometry StudyPLOS ONE, 2012
- Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestationsNeurological Sciences, 2011
- Are Acquired Hepatocerebral Degeneration and Hepatic Myelopathy Reversible?Journal of Clinical Gastroenterology, 2009
- Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degenerationMovement Disorders, 2008
- An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: Further studies using NMR spectroscopyNeurochemistry International, 2005
- Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)Movement Disorders, 2005
- Hepatic myelopathy Case report with review of the literatureClinical Neurology and Neurosurgery, 1996
- Chronic acquired hepatocerebral degeneration: Case reports and new insightsMovement Disorders, 1995
- Improvement in chronic hepatocerebral degeneration following liver transplantationGastroenterology, 1990